Get started
DAIICHI SANKYO CO. LTDDAIICHI SANKYO CO. LTDDAIICHI SANKYO CO. LTD

DAIICHI SANKYO CO. LTD

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

D4S chart


Full chart

D4S upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪51.48 B‬ EUR
Dividend yield (indicated)
1.37%
Price to earnings Ratio (TTM)
33.73
Basic EPS (TTM)
0.82 EUR
Net income (FY)
‪1.23 B‬ EUR
Revenue (FY)
‪9.81 B‬ EUR
Shares float
‪1.62 B‬
Beta (1Y)
0.90

Employees


Employees (FY)
‪18.73 K‬
Change (1Y)
‪+1.29 K‬ +7.40%
Revenue / Employee (1Y)
‪523.74 K‬ EUR
Net income / Employee (1Y)
‪65.64 K‬ EUR

About DAIICHI SANKYO COMPANY LIMITED


Sector
Health Technology
CEO
Sunao Manabe
Headquarters
Tokyo
Website
daiichisankyo.co.jp
Founded
2005
ISIN
JP3475350009
FIGI
BBG000DXRMJ4
Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceuticals. Its products include drugs for the field of oncology such as Trastuzumab deruxtecan, Anti-HER3-ADC, Quizartinib, Milademetan, Valemetostat, Pexidartinib, Edoxaban, Prasugel, and Microgabalin. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

D4S news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of D4S is 26.51 EUR — it has decreased by −2.00% in the past 24 hours. Watch DAIICHI SANKYO CO. LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange DAIICHI SANKYO CO. LTD stocks are traded under the ticker D4S.
D4S stock has fallen by −0.26% compared to the previous week, the month change is a −1.63% fall, over the last year DAIICHI SANKYO CO. LTD has showed a 10.14% increase.
We've gathered analysts' opinions on DAIICHI SANKYO CO. LTD future price: according to them, D4S price has a max estimate of 47.92 EUR and a min estimate of 35.31 EUR. Watch D4S chart and read a more detailed DAIICHI SANKYO CO. LTD stock forecast: see what analysts think of DAIICHI SANKYO CO. LTD and suggest that you do with its stocks.
D4S reached its all-time high on Sep 3, 2024 with the price of 37.90 EUR, and its all-time low was 3.72 EUR and was reached on Jan 9, 2015. View more price dynamics on D4S chart.
See other stocks reaching their highest and lowest prices.
D4S stock is 2.04% volatile and has beta coefficient of 0.90. Track DAIICHI SANKYO CO. LTD stock price on the chart and check out the list of the most volatile stocks — is DAIICHI SANKYO CO. LTD there?
Today DAIICHI SANKYO CO. LTD has the market capitalization of ‪50.92 B‬, it has decreased by −5.08% over the last week.
Yes, you can track DAIICHI SANKYO CO. LTD financials in yearly and quarterly reports right on TradingView.
DAIICHI SANKYO CO. LTD is going to release the next earnings report on Jan 29, 2025. Keep track of upcoming events with our Earnings Calendar.
D4S earnings for the last quarter are 0.20 EUR per share, whereas the estimation was 0.15 EUR resulting in a 31.42% surprise. The estimated earnings for the next quarter are 0.18 EUR per share. See more details about DAIICHI SANKYO CO. LTD earnings.
DAIICHI SANKYO CO. LTD revenue for the last quarter amounts to ‪2.79 B‬ EUR, despite the estimated figure of ‪2.68 B‬ EUR. In the next quarter, revenue is expected to reach ‪2.90 B‬ EUR.
D4S net income for the last quarter is ‪382.98 M‬ EUR, while the quarter before that showed ‪495.18 M‬ EUR of net income which accounts for −22.66% change. Track more DAIICHI SANKYO CO. LTD financial stats to get the full picture.
DAIICHI SANKYO CO. LTD dividend yield was 1.05% in 2023, and payout ratio reached 47.76%. The year before the numbers were 0.62% and 52.67% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 22, 2024, the company has ‪18.73 K‬ employees. See our rating of the largest employees — is DAIICHI SANKYO CO. LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. DAIICHI SANKYO CO. LTD EBITDA is ‪1.96 B‬ EUR, and current EBITDA margin is 15.62%. See more stats in DAIICHI SANKYO CO. LTD financial statements.
Like other stocks, D4S shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DAIICHI SANKYO CO. LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So DAIICHI SANKYO CO. LTD technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating DAIICHI SANKYO CO. LTD stock shows the sell signal. See more of DAIICHI SANKYO CO. LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.